Mark Ramirez's Articles in Others

  • FDA Releases New Plan to Shape-Up System
    In response to recent heavy criticism received by the FDA, the FDA unveiled a new set of codes on Tuesday hoping to upgrade the safety operations found in the US.
  • Birth Control Pills: They Don’t Make’em Like They Use To
    Do to the deteriorated effectiveness of recent birth control medication, the FDA has decided to assemble a panel in order to determine if new contraceptive medication should be required to meet a higher standard of quality.
  • 1930’s Remedy Curing Diabetes?
    Mary Vernon has been using a treatment that has been abandoned since the 1930’s. The worst part, the treatment that is the opposite of guidelines set by the American Diabetes Association, has been working.
  • Not Just Big Pharma: Biotech Companies Fighting Over Drug Patents
    Barr Pharmaceuticals is lobbying for a US law that would allow the sale of copied medicines made by the biotech industry. Barr is dispatching almost a dozen representatives along with many other generic drug lobbyists, to try to pass their law.
  • Could RX Master Help You Conquer Your Medication?
    The Rx Master is a carrying case for your medications, with built in pill drawers keeping each day’s medication separate. On top of those compartments sits a computer that will inform you of any possible interactions with other drugs or food you are consuming, side affects, and risk of addiction.
  • House Hopes to Use Leverage to Negotiate Lower Drug Prices
    The enactment of Nanci Pelosi’s first hundred hours has begun, and house democrats are searching for ways to fulfill her goal of lowering the price of prescription medication for seniors using Medicare.
  • Zofran Generic Approved
    This article talks about the recent FDA approval of the generic form of Zofram to be produced by Dr. Reddy Laboratories of Bridgewater, N.J.; Kali Laboratories of Somerset, N.J.; and Roxane Laboratories of Columbus, Ohio.
  • Will New Rules From the Bush Administration Help Medicaid?
    According to the New York Times, on Monday the Bush administration proposed a new rule to reduce reimbursements to pharmacists for Medicaid beneficiaries. If implemented, the new rule is expected to save $8.4 billion dollars over the next five years, $4.9 billion in federal savings and $3.5 billion in local savings for states.

  Site Links We Support:
  Home
About Us
Contact Us
RSS Feeds
Privacy Policy
Terms of Service
Link Partners
 
 


**scoop**

Powered by Article Dashboard